Statistics and Outcomes

Blood and Marrow Transplant Survival Rates

Blood and Marrow Transplantation is used to treat a number of cancers, blood diseases and immune disorders that were once considered incurable. The BMT program at Children's is accredited by the Foundation for the Accreditation of Cellular Therapy (FACT).

Blood and Bone Marrow Transplant (2008-December 2013)
Outcome Measure Type Children's Hospital
100-Day Survival1 All** 97%
One-Year Non-Relapse Mortality2 All**
One-Year Overall Survival3 All**

** Includes auto-BMT, allo-related BMT, allo-unrelated and cord blood transplants.

1 Percentage of patients living 100 or more days following the transplant procedure (This takes into account deaths due to transplant- and disease-related causes.)

2 Percentage of patients who died due to causes other than related to underlying disease

3 Percentage of patients living one or more years following the transplant procedure

Blood and Marrow Transplant Volumes

Transplant Type 2014 Program Inception Through 12/31/2013
Allo Blood and Marrow Transplants 24 287
Auto 10 181
Total 34 468

Sources: Internal data, Hillman Center for Pediatric Transplantation; Scientific Registry of Transplant Recipients (, December 2015 release.